Table 3.
Among Young People with Stimulant Prescriptions, Percentages with Any Psychosocial Service and Any Mental Disorder Diagnosis, and Among this Group Select Mental Disorder Diagnoses, United States 2009
| Age (years) | ||||
|---|---|---|---|---|
| 3–5 (%) | 6–12 (%) | 13–18 (%) | 19–24 (%) | |
| Among youth with stimulant prescriptions | ||||
| With ≥1 psychosocial service visit | 9.9 | 8.8 | 12.0 | 9.6 |
| With any mental disorder diagnosis | 43.1 | 45.2 | 33.8 | 29.0 |
| Among youth with stimulant prescriptions and a mental disorder diagnosis | ||||
| With ≥1 ADHD diagnosis | 85.4 | 90.6 | 81.4 | 71.9 |
| With ≥1 disruptive behavior diagnosis | 10.0 | 5.7 | 5.1 | 0.7 |
| With ≥1 mood disorder diagnosis | 2.3 | 4.5 | 14.2 | 22.2 |
| With ≥1 anxiety disorder diagnosis | 3.3 | 4.4 | 6.6 | 13.9 |
| With ≥1 other mental disorder diagnosis | 11.8 | 7.8 | 7.5 | 5.9 |
IMS LifeLink® Information Assets-LRx Longitudinal Prescription Database, 2009, IMS Health Incorporated.
ADHD, attention-deficit/hyperactivity disorder.